Accounts Receivable, after Allowance for Credit Loss, Current in CAD of Arbutus Biopharma Corp from Q4 2010 to Q4 2013
-
Taxonomy & unit
-
us-gaap: USD and CAD
-
Description
-
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
-
Summary
-
Arbutus Biopharma Corp quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and change rate from Q4 2010 to Q4 2013.
- Arbutus Biopharma Corp Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 31 Dec 2013 was CA$117K, a 89.2% decline year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (CAD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)